GlassScriptPhysician profile
Moses D Salgado
NPI 1235345489
$4,927.75
in general payments reported to CMS, 2019-2025
17 companies · $243 in 2025
The $243 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,952 · 2020: $148 · 2021: $272 · 2022: $476 · 2023: $552 · 2024: $285 · 2025: $243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,080.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,079.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $1,948.61 | 2019-2020 | |
| Inspire Medical Systems, INC. | $998.32 | 2019-2024 | Inspire |
| Stryker Corporation | $461.32 | 2019-2023 | Scopis Ent, Clarifix Cryotherapy Device |
| Smith+Nephew, INC. | $323.57 | 2019-2025 | Tula, Halo |
| Genzyme Corporation | $279.72 | 2022-2025 | |
| Optinose US, INC. | $261.70 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $181.00 | 2020-2025 | Dupixent |
| Ethicon US, LLC | $84.97 | 2021 | |
| Neurent Medical Limited | $74.06 | 2022-2023 | Neuromark Device, Neuromark Radiofrequency Console |
| Aerin Medical INC. | $67.02 | 2020-2025 | |
| Alk-Abello, INC | $62.82 | 2019-2023 | Grastek, Odactra, Ragwitek |
| Glaxosmithkline, LLC. | $54.02 | 2023-2024 | Nucala |
| Itamar Medical INC | $35.46 | 2022-2025 | Watchpatone |
| Sanofi-Aventis U.S. LLC | $29.52 | 2021 | |
| Karl Storz Endoscopy-America | $26.17 | 2023 | N.A. |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $20.07 | 2023 | Sinuva |
| Merck Sharp & Dohme LLC | $19.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Moses Salgado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.